Related Experiment Video
Updated: Aug 9, 2026
11:15
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
Mutational analysis of human tumor necrosis factor-alpha
Hang-Cheol Shin1, Kwang-Hwi Cho
1Department of Bioinformatics and Life Science, and Computer Aided Molecular Design Research Center, Soongsil University, Seoul, Korea, 156-743. hcshin@ssu.ac.kr
Biotechnology Letters
|February 11, 2005
Summary
Mutational analysis of human tumor necrosis factor-alpha (TNF-alpha) identified key regions influencing its bioactivity. Specific mutations in regions 1 and 4 enhance cytotoxic activity, offering potential for therapeutic agent design.
Area of Science:
- Biochemistry
- Molecular Biology
- Immunology
Background:
- Human tumor necrosis factor-alpha (TNF-alpha) is a critical cytokine involved in inflammation and immunity.
- Understanding its structure-function relationship is essential for developing targeted therapies.
Purpose of the Study:
- To investigate the structure-function relationship of human TNF-alpha through mutational analysis.
- To identify specific molecular regions critical for TNF-alpha bioactivity and cytotoxic function.
Main Methods:
- Site-directed mutagenesis was performed on lower regions (1-6) of the human TNF-alpha molecule.
- A chaperonin co-expression system was used to produce soluble muteins.
- Cytotoxic activity of purified muteins was assessed using TNF-sensitive murine fibrosarcoma L929 cells.
Main Results:
- Mutations in regions 1 (residues 1-10), 2 (residues 37-41), and 4 (residues 84-88) significantly impacted TNF-alpha bioactivity.
- Region 1 mutations affecting charge and deletion length influenced maximum activity.
- Introduction of charged residues in region 4 (positions 86-88) markedly increased cytotoxic activity.
- Mutations in region 2 had a detrimental effect on bioactivity.
Conclusions:
- The study elucidates critical structural determinants of human TNF-alpha's bioactivity.
- Specific modifications in regions 1 and 4 can enhance TNF-alpha's cytotoxic potential.
- Findings provide a structural foundation for designing potent TNF-alpha-based therapeutic agents.
